Inventor
Tomas Norling
Inventor
Lyngby, DK
Overview
Patents· 23 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes42%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests19%
H04LTransmission of digital information, e.g. telegraphic communication2%
H04WWireless communication networks2%
PatentTitleYear
11,123,331Tacrolimus for improved treatment of transplant patients202111,110,081Tacrolimus for improved treatment of transplant patients202111,077,096Modified release compositions comprising tacrolimus202110,864,199Tacrolimus for improved treatment of transplant patients20209,757,362'Modified release compositions comprising tacrolimus'20179,173,847'Tablet comprising a fibrate'20159,161,907'Modified release compositions comprising tacrolimus'20158,889,186'Modified release compositions comprising tacrolimus'20148,889,185'Modified release compositions comprising tacrolimus'20148,685,998'Tacrolimus for improved treatment of transplant patients'20148,664,239'Tacrolimus for improved treatment of transplant patients'20148,623,410'Modified release compositions comprising tacrolimus'20148,623,411'Modified release compositions comprising tacrolimus'20148,617,599'Modified release compositions comprising tacrolimus'20138,586,084'Modified release compositions comprising tacrolimus'20138,582,444'Method for detecting hardware faults by determining a ratio of released connections'20138,481,078'Solid dosage form comprising a fibrate'20138,124,125'Solid dosage form comprising a fibrate'20127,658,944'Solid dosage form comprising a fibrate'20106,228,383'Use of fatty acid esters as bioadhesive substances'20015,958,458'Pharmaceutical multiple unit particulate formulation in the form of coated cores'19995,955,502'Use of fatty acid esters as bioadhesive substances'19995,143,934'Method and composition for controlled delivery of biologically active agents'1992Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1992–1999Patents assigned to DUMEX LTD AS (2)· patent assignee history
1992Based in Copenhagen, DK· patent location history
1999–2021Based in Lyngby, DK· patent location history
2012–2021Patents assigned to VELOXIS PHARMACEUTICALS AS (17)· patent assignee history
2012–2015Patents assigned to NORLING TOMAS (10)· patent assignee history
2012–2015Patents assigned to HOLM PER (9)· patent assignee history
2013Based in Stockholm, SE· patent location history
2021Patents assigned to VELOXIS PHARMACEUTICALS INC (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| VELOXIS PHARMACEUTICALS AS | 17 | 2012–2021 |
| NORLING TOMASself | 10 | 2012–2015 |
| HOLM PER | 9 | 2012–2015 |
| VELOXIS PHARMACEUTICALS INC | 3 | 2021 |
| DUMEX LTD AS | 2 | 1992–1999 |
Locations
| Location | Patents | Span |
|---|---|---|
| Lyngby, DK | 21 | 1999–2021 |
| Stockholm, SE | 1 | 2013 |
| Copenhagen, DK | 1 | 1992 |